Dynamic modelling of biochemical reaction networks has to cope with the inherent uncertainty about biological processes, concerning not only data and parameters but also kinetics and structure. These different types of uncertainty are nested within each other: uncertain network structures contain uncertain reaction kinetics, which in turn are governed by uncertain parameters. Here we review some issues arising from such uncertainties and sketch methods, solutions and future directions for dealing with them.
Introduction
Mathematical modelling of dynamic biological processes is an integral part of systems biology.
Mathematical models have proven to be very useful to explain physical and biological principles since over two centuries. Nowadays, models are also widely used to address more specific questions arising from biological and medical experiments. The choice of the model type crucially depends on the question we have about the system. General questions such as "what are the possible reaction mechanisms that result in a step-like dose-response curve?" or "what mechanism can explain hysteresis?" can be approached by mathematical models that one can solve with paper and a pencil [1, 2] . However, to model specific systems in a quantitative manner, we need to confront our understanding of complex reaction networks with experimental data at hand and to use computationally more demanding approaches, like systems of differential equations. When model development is driven by experimental data, the focus is not only on qualitative types of behaviour but rather on quantitative predictions. When constructing a biochemical model, a number of choices have to be made: we have to choose an appropriate model structure based on hypothesized interactions of biochemical components, and for the reactions, we have to choose kinetic rate laws and the corresponding enzymatic parameters. At this stage, the true wiring scheme and the true parameters are uncertain. These uncertainties need to be resolved by confronting model alternatives with experimental data. Even after considering the data, some of the uncertainty will remain, but this uncertainty can in turn be quantified: uncertainty in parameters can be described by confidence intervals or posterior probability densities, while uncertainty in structures can be described by probabilities or rankings of models.
However, network structure, kinetic laws and kinetic parameters cannot be determined independently: on the one hand, we need to specify model structure and kinetics in advance to determine kinetic constants. On the other hand, to choose between model structures, we need to judge their quality, for instance, by their ability to reproduce given data. Hence, the uncertainties on different levels are nested and have to be resolved by a combination -or rather, iteration -of model selection and parameter fitting.
In the following, we review some issues arising from uncertainties concerning kinetic constants, kinetic laws, and network structure. We sketch problems, solutions, and future directions for dealing with them and present workflows that handle uncertainties in a consistent and rational way.
Parameter Uncertainty
Let us first assume that the structure and kinetic laws of a biochemical network are known and just the parameter values θ need to be determined. Available parameter values may be uncertain due to experimental errors or biological variability or because they were measured in vitro. For other parameters, we may only have rough guesses about the order of magnitude or no information at all. A second source of information are dynamical data: if a model successfully describes, for instance, concentration time courses, the parameter values used will seem more plausible. In parameter estimation, we intend to determine the most plausible parameter values given all available information and to assess the remaining uncertainty about them. Some methods will yield, as a result, confidence intervals or probability distributions for the parameters. This information can later be used to assess the uncertainty of model results via Monte Carlo sampling.
Maximum Likelihood Estimation
If parameter values are completely unknown in advance, a standard way to determine them is to fit the model to sets of experimental data y. Such a parameter estimation is usually based on the principle to maximise the likelihood
defined as the probability to observe the data y from model f with parameter vector f θ . We shall not explicitly mention the model subscript f henceforth. Under the assumption of independent Gaussian measurement errors, maximising the likelihood is equivalent minimising the sum of squared residuals (SSR), i.e., the squares of the distance between experimental data points and the respective results of the model simulation. With given data y, the SSR is a function of the parameter vector and parameter boils down to finding the minima of this function. 4 The main problems in parameter optimisation are (i) the non-linear nature of ODEs, causing numerical instabilities in the calculations, (ii) the high dimensionality of the parameter space, possibly leading to many local minima and (iii) the notorious disproportion between a small number of data points and a large number of parameters, which results in overfitting. In summary, we face a number of risks including not to sample the parameter space appropriately, to be stuck in a local minimum, to find a global minimum that is still different from the biological reality, or to proceed too slowly in approaching the minimum. If we need to rule out suboptimal local minima, we cannot use local gradient-based methods, but must use global, computationally demanding methods. An overview over the most popular parameter estimation algorithms in biology and biochemistry is given in [3] . A number of algorithms are implemented in systems biology tools such as Copasi [4] , SBML-PET [5] , or SBToolBox [6] .
Bayesian parameter estimation
If prior information about model parameters is available (e.g., ranges or probability distributions for kinetic constants), it should be taken into account in the parameter estimation.
Bayesian parameter estimation methods [7] can determine a compromise between such prior knowledge and the information obtained from the likelihood function. The result is a posterior probability distribution over the parameter sets: a high probability shows that a certain parameter set seems plausible in the light of all information considered.
Formally, model parameters θ and experimental data y are described by a joint probability In simple cases (e.g., linear models and Gaussian distributions), the posterior can be computed analytically. If this is not possible, it can be characterized by sampling methods like Monte Carlo Markov Chains [7] or approximated, for instance, by a Gaussian distribution [8] . A Gaussian posterior represents a most plausible parameter set (the center of the Gaussian) together with the remaining uncertainties (given by the covariance matrix); this information can be used as a starting point for further modelling. Bayesian methods in bioinformatics and computational systems biology have been reviewed recently [9] .
Estimation of kinetic constants based on heterogeneous and uncertain data
Many kinetic parameters have been published in the literature, but they cannot be directly inserted into models: parameters measured in vitro or under different conditions may be unreliable or incompatible with each other [10] . To obtain a consistent, complete set of kinetic parameters, we need to guess the uncertainties of known values, make reasonable assumptions about unknown values, and find a "balanced" parameter set that appears most plausible in the light of all parameter values collected. Bayesian statistics provides a rational way to do that.
Parameter balancing
Statistical distributions can be used to describe actual parameter variability (e.g., protein expression) within cell populations, but also our ignorance or beliefs about parameter values.
In Bayesian parameter balancing, measured parameter values are treated as data y and each kinetic parameter has a prior distribution that expresses our general beliefs. The empirical distribution of all known K M values, for instance, may serve as a prior for an unknown K M 6 value [11] . Eventually, we obtain a posterior distribution that describes the remaining uncertainty owing to missing knowledge, measurement uncertainties or biological variability.
The resulting posterior distribution can be used to sample parameter sets for Monte-Carlo simulations, which in turn give us probabilistic statements about the dynamic behaviour of the model (analytic results within a linear approximation are described in [12] ).
If we intend to describe kinetic parameters by probability distributions, a problem remains to be solved: thermodynamic laws may lead to dependencies among the parameters in a network, so drawing parameters independently from a statistical distribution would almost certainly lead to thermodynamically wrong models. Thus, we need to construct a parameter distribution that satisfies the thermodynamic constraints. The key idea is to choose a different parametrisation of the model, in which any combination of parameter values is feasible: several approaches have been developed for this purpose [8, 13, 14] . As an example, we shall discuss here parameter balancing for the convenience kinetics [8] .
Convenience kinetics
The convenience kinetics [8] is a generalised form of the Michaelis-Menten kinetics for arbitrary numbers of substrates and products (figure 1). It allows for describing enzyme saturation, inhibition, and activation and can be used to model enzymes with unknown kinetic law. For a two-substrate/one product reaction A + B ↔ C with an activator X and an inhibitor Y (concentrations a, b, c, x, y), the reaction rate reads
where E denotes the enzyme concentration and there are the two turnover rates k + and k -for the two reaction directions.
[place Figure 1 around here]
Thermodynamically correct parameters and parameter balancing
If chemical reactions form a reaction network, the kinetic constants of different reactions are constrained by thermodynamic laws. In order to yield a zero reaction rate at thermal equilibrium, the parameters have to satisfy the Haldane relation
where the equilibrium constant k eq =c/(a·b) denotes the concentration ratio in thermodynamic equilibrium. For thermodynamic reasons, the equilibrium constant is determined by the Gibbs free energies of formation of the reactants via
where R is Boltzmann's gas constant and T is the temperature in Kelvin.
The two equations (2) and (3) together lead to -possibly complicated -constraints between the parameters [8] . This problem -which would also arise with reversible mass-action or Michaelis-Menten kinetics -can be solved by introducing a new parametrisation. By rewriting equation (2) as
and inserting equation (3), we obtain
If we introduce a new parameter (``velocity constant'')
we can express the turnover rates k + and k -by the remaining parameters
With this equation, an entire network model can be parametrised in a thermodynamically correct manner: the reactant constants (k A etc.), Gibbs free energies of formation (G A (0) etc.), and velocity constants (k R ) are regarded as model parameters, which are thermodynamically unconstrained and for which probability distributions can be specified. The turnover rates , on the other hand, are computed from the model parameters. For an entire model, we collect the independent parameters (in logarithmic form as above) in a vector θ and all kinetic parameters (including the dependent ones, also in logarithmic form), in a vector x. Both vectors are then related by a linear equation
where the matrix can be easily derived from the network structure [8] . 
Prior distributions for kinetic parameters
Bayesian parameter estimation relies on an appropriate choice of the prior distributions. In parameter balancing, for instance, the prior is especially important for those parameters in the vector θ for which no data are available. To specify a prior, we need to specify both the mathematical form (e.g., log-normal distribution) and the hyperparameters (e.g. mean values and covariances) that determine its exact size and shape. Gaussian distributions for logarithmic kinetic parameters are biologically plausible and together with the linear relation like equation (5) lead to a simple Gaussian posterior. 10 To determine the prior mean and width for a certain parameter type, say K M values, one could fit a Gaussian distribution to the empirical distribution of all logarithmic K M values available in databases like Brenda [16] . More accurate priors can be derived for individual K M values based on analysis of variance (ANOVA) with the enzyme and the organism as factors [11] . We applied this analysis to log 10 K M values from the enzyme database Brenda and assessed the quality of predictions with leave-one-out cross-validation. The quality of predictions depended on the studied substrate. The overall correlation coefficient between measured and predicted log 10 K M was 0.77. The resulting predictions and error ranges for enzyme parameters can be used for defining individual priors for k M values in convenience kinetics [11] .
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A Workflow for Building Kinetic Models
We have assembled the methods and protocols into a modelling workflow [17] that facilitates the integration of biochemical data and the modelling of metabolic networks from scratch (see Figure 2 ).
In brief, it translates a given metabolic network structure into a draft version of a kinetic model with convenience kinetics; known kinetic laws [18] can also be inserted into the models. Such an automatic workflow can not replace manual kinetic modelling, but it can ease it: effectively, the workflow provides modellers with a simple way to query several enzyme databases in the context of a specific model. The result is a posterior parameter distribution that can be used to define parameter ranges for further manual modelling, and it can be directly used as a parameter prior for model fitting. The variances of model parameters show where information is missing and can point at additional measurements that would provide the most valuable information.
Uncertainty about kinetic rate laws and network structure
Although parameter estimation is a demanding issue in itself, the main challenge in modelling is often to determine the structure of the network, in terms of choosing appropriate rate laws, i.e. kinetics, as well as the wiring scheme itself. Metabolic networks are to a large extent specified by a list of enzymes, which can be obtained from genome sequencing, sequence comparison and traditional biochemical protein characterization and function identification. 12 Still, there is some uncertainty, since not all enzymes are identified and the role of isoenzymes is not always clear. This is also documented by the regular updates of large-scale stoichiometric metabolic models [19, 20] . 
23])
. A model of this type represents the compounds or processes that are considered important 13 or relevant: in a way, it summarizes literature and expert knowledge (and convention) and employs it to answer specific questions, for instance, to predict the behaviour of a compound that is experimentally not accessible.
Automatic construction of candidate models
There are several practical issues related to the modelling of uncertainty of network structures.
Possible combinations of uncertain structures and kinetics directly translate into alternative mathematical models. Generating and handling such alternative models poses a considerable challenge to the modeller for several reasons. First, each model has to be implemented, simulated and analysed separately. Often, model alternatives vary only slightly in structure and/or kinetics. This may seduce the modeller to copy-paste the original model and then introduce the modifications by hand. This is an error-prone process. Secondly, changes that affect the whole family of models have to be updated in each model separately, which is also an error-prone and tedious task, especially when the number of models is high. The combinatorial complexity often renders it impossible to implement and handle each model individually. Several formalisms and tools were developed to address these problems. We can roughly distinguish between two groups: some of them help to automatically generate models and others handle the combinatorial complexity.
As examples for the first group, the tools Cellerator [24] and MMT2 [25] can be mentioned.
Cellerator is a Mathematica ® package designed to facilitate biological modelling via automated equation generation. Reactions are specified by an arrow-based reaction notation from which a single model is created. MMT2 is a software tool that produces all possible network variants of metabolic networks by switching reactions off and on. Subsequently, unrealistic models are sorted out by analysis of extreme pathways and elementary flux modes.
14 As examples for the second group, BioNetGen [26] and Moleculizer [27] can be mentioned.
BioNetGen is a language that focuses on protein-protein interactions. The user can specify rules from which one single model is created automatically. BioNetGen is designed to handle combinatorial complexity of protein complex formation with modifications, e.g., a receptor with n phosphorylation sites can occupy 2 n different states; if it dimerizes 2 2n , different states are allowed, etc. Moleculizer is a stochastic simulator for intracellular biochemical systems, with special treatment for protein complexes. It resembles BioNetGen but avoids using the network of all possible complexes and reactions, based on their probability of occurrence. Only one single model is generated and simulated.
These state-of-the-art approaches have a major short-coming: even though most tools aim at handling combinatorial complexity, they produce only one model at the end, which includes all or a reduced number of possible molecular interactions generated from certain rules. Currently, there is no tool that automatically implements and manages different models, which differ in the number of components, reactions and kinetics. However, this is what modellers in systems biology are confronted with. MMT2 aims into that direction but it falls short in the ability to actually control the kind of generated models, because it does not allow for alternatively removing components or employing alternative kinetics.
In our daily work and discussions with the community, we see that it is not so much the combinatorial complexity that creates problems for the modellers but rather to manage and handle a specific set of candidate models. Often modellers have a very clear idea what different versions of a model they want to implement, simulate, and fit to data. It is just tedious and error-prone to it all by hand.
Another hotly debated issue is model documentation [28, 29] . It is not only the successful models that are of interest to the research community, but also those that failed. Usually, in the course of a modelling project many unsuccessful model versions are tested but only the 15 successful one is finally published. The unsuccessful versions, even though of interest, are never documented, because this is also a laborious task and not rewarded. Finally, having several model alternatives at hand, it is again painful to simulate each one individually and to compare the results to select and refine the best ones.
In order to handle uncertainty in kinetics and model structure, we envision a tool that automatically generates candidate models based on a root or master model and specified modifications and directives. The generated models are automatically documented in a way that it is always comprehensible how they were derived from the master model, thereby keeping track of model versions and alternatives. This would facilitate that common parameters, modifications or directives are changed in one place only and automatically updated in each model, which removes the errors introduced by modifying each model
individually. Finally, all generated models are simulated, fitted to data, and compared automatically. At the end the user could be provided with a ranking of the model fits and statistical measures that enables him to discriminate between model alternatives.
Model selection and nested uncertainty
To cope with the uncertainty in structure or kinetic laws, one may either choose the most plausible or most interesting network structure or one may fit all model alternatives, including alternative structures and kinetics, to the available experimental data. There exist a number of criteria to discriminate or select among alternative fitted candidate models. For nested models, i.e. where a model is a restricted version of the other one, statistical measures like F-test or
Likelihood-ratio-test can be used. Nested and non-nested models can be ranked according to the Akaike information criterion AIC [30, 31] , the minimum description length (MDL) [32] or others criteria that are based on information theory. The model with the lowest AIC or MDL is selected (for a review on model selection see [33] ). 16 Alternative model structures can be generated from a master model, which includes all possible components and reactions, by leaving out sets of specified components and/or reactions. In this way, an acyclic graph of models is created that are partly nested within each other. From these alternative model structures, alternative kinetic variants are derived that in turn can be nested within each other. These model alternatives are eventually fitted to data. to the problem of model structure and parameter value estimation: if knowledge about a mutant was used to define the network structure, then correct prediction of the mutant behaviour is a necessary condition to accept the model, not a new prediction. Another useful test, for example of signalling pathway models, is the prediction of the effect of external changes that are related to, but quantitatively different from, the external changes considered originally, e.g. different stress strengths [34] .
Thus, model selection or system identification should be in fact an iterative procedure of repeated cycles of producing candidate models, parameter fitting and predictions [35] .
Discussion
Building of dynamical cell models is hampered by difficulties on various levels: despite strong efforts in high-throughput and high-quality data generation, we still face a lack of good quantitative time-resolved data and derived kinetic parameters. In principle, parameters can also be estimated from model fitting, but parameter estimation methods are often not powerful enough to cope with large non-linear differential equations systems and sparse data. Finally, we have to manage the nested uncertainty in model structure, rate laws and parameter values.
Although the systems biology community is developing methods and tools to handle these issues, they are still largely unresolved and need further efforts.
We have discussed here practical and theoretical issues related to construction of biochemical models. To integrate diverse data into models with given network structure, one may explicitly consider parameter distributions instead of fixed parameter values. After collecting original data about kinetic constants, Bayesian balancing allows to combine them with relatively loose prior assumptions. The result is a kinetic model with convenience rate law and balanced, consistent parameters. The parameter posterior can also be used as a prior for further rounds of 18 Bayesian estimation in which dynamic quantities -such as measured metabolite concentrations and fluxes -are integrated.
Statistical and information theory provides some theoretical approaches to discriminate between rival model formulations, concerning both structure and kinetics. Generally, we gain more confidence in our understanding of biological processes by iteratively constructing model variants, estimate parameters and predict independent experiments. However, we still see a lack of practical tools that facilitate management and handling of alternative model formulations.
Dynamic modelling of cellular networks often has to cope with data of poor quality, such as missing or contradictory parameters, data obtained from different experiments, or in-vitro data.
Even the best modelling workflow and model management tool cannot construct a reliable model from poor data.
We expect that larger amounts of specific, high-quality, quantitative, time-resolved, single-cell data will be available in the near future. This will help us to understand the organization and regulatory principles of metabolic or signalling pathways and will enable us to derive useful predictions from the models. 
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